🔎 Trials Near Me

Home › Aortic Arch Aneurysm › NCT07166133

GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study

Recruiting

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

1. Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements.
2. Patient has been or is intended to be treated with the TBE Device in Zone 0 or Zone 1.
3. Patient is age ≥ 18 years at time of informed consent signature.

Exclusion Criteria:

1. Patient who is, at the time of consent, unlikely to be available for defined follow-up visits.
2. Patient with exclusion criteria required by local law.
3. Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or investigational device study within 12 months of study enrollment. Subjects cannot be enrolled in another Gore study.

About the study

A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.

What is being tested

Sponsor: W.L.Gore & Associates · Participants: 125 · Started: Mar 2, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07166133

Locations in the U.S.

ArizonaHonorHealth, Scottsdale
CaliforniaKeck Medical Center of USC, Los Angeles
University of California Davis Health System, Sacramento
ConnecticutHartford Hospital, Hartford
District of ColumbiaMedStar Washington Hospital Center, Washington D.C.
FloridaUniversity of Florida Health Heart & Vascular, Gainesville
Lakeland Regional Medical Center, Lakeland
University of South Florida, Tampa
MarylandJohns Hopkins University, Baltimore
North CarolinaUniversity of North Carolina at Chapel Hill, Chapel Hill
Duke University Medical Center, Durham
PennsylvaniaThomas Jefferson University, Philadelphia
Allegheny General Hospital, Pittsburgh
TexasThe Methodist Hospital-Houston, Houston
Baylor Scott & White Research Institute, Plano
UtahIntermountain Medical Center, Murray
WashingtonUniversity of Washington Medical Center, Seattle
WisconsinUniversity of Wisconsin - Madison, Madison
Medical College of Wisconsin, Milwaukee

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.